rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
DISHMAN PHARMACEUTICALS & CHEMICALS LTD. - Updates
Download announcement < Back
02 Feb 2017
Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that the Companys Bavla facility was successfully inspected by the US FDA in July, 2016, which was intimated to the stock exchanges on July 09, 2016. In this regard, the Company has received the Establishment Inspection Report (EIR) from the US FDA for this facility on February 01, 2017.&lt;BR&gt;&lt;BR&gt;Thus, the Companys facilities in Bavla, Naroda and Switzerland continue to be approved by the US FDA.
View all announcements for DISHMAN PHARMACEUTICALS & CHEMICALS LTD. Source: BSE India